Synairgen plc (LON:SNG – Get Free Report)’s stock price reached a new 52-week low on Wednesday . The stock traded as low as GBX 3 ($0.04) and last traded at GBX 3.35 ($0.04), with a volume of 101650 shares trading hands. The stock had previously closed at GBX 3.45 ($0.05).
Synairgen Price Performance
The company has a 50-day moving average of GBX 4.43 and a 200-day moving average of GBX 5.35. The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77. The firm has a market capitalization of £6.75 million, a price-to-earnings ratio of -83.75 and a beta of -2.23.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Featured Articles
- Five stocks we like better than Synairgen
- Breakout Stocks: What They Are and How to Identify Them
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- Are Penny Stocks a Good Fit for Your Portfolio?
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
